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Genetic Dissection of the Signaling 
Cascade that Controls Activation 
of the Shigella Type III Secretion 
System from the Needle Tip
I. Murillo1, I. Martinez-Argudo1,2 & A. J. Blocker3
Many Gram-negative bacterial pathogens use type III secretion systems (T3SSs) for virulence. The 
Shigella T3SS consists of a hollow needle, made of MxiH and protruding from the bacterial surface, 
anchored in both bacterial membranes by multimeric protein rings. Atop the needle lies the tip complex 
(TC), formed by IpaD and IpaB. Upon physical contact with eukaryotic host cells, T3S is initiated leading 
to formation of a pore in the eukaryotic cell membrane, which is made of IpaB and IpaC. Through the 
needle and pore channels, further bacterial proteins are translocated inside the host cell to meditate 
its invasion. IpaD and the needle are implicated in transduction of the host cell-sensing signal to the 
T3S apparatus. Furthermore, the sensing-competent TC seems formed of 4 IpaDs topped by 1 IpaB. 
However, nothing further is known about the activation process. To investigate IpaB’s role during 
T3SS activation, we isolated secretion-deregulated IpaB mutants using random mutagenesis and 
a genetic screen. We found ipaB point mutations in leading to defects in secretion activation, which 
sometimes diminished pore insertion and host cell invasion. We also demonstrated IpaB communicates 
intramolecularly and intermolecularly with IpaD and MxiH within the TC because mutations affecting 
these interactions impair signal transduction.
Type III secretion systems (T3SSs) are macromolecular structures used by many Gram-negative bacteria. They 
deliver protein “effectors of virulence” into eukaryotic host cells1 to modulate biochemical pathways in favor of 
the bacterium2. We study the T3SS of Shigella flexneri, the agent of human bacillary dysentery, focusing on traits 
conserved in all species, such as physical sensing of host cells.
Shigella is an enteropathogen causing ~165 million diarrheal episodes per year worldwide, with a 10% fatality 
rate for children in the developing world3. Shigella invades the colonic epithelium. Once inside an epithelial cell, 
it escapes from the vacuole, replicates within the cytoplasm and disseminates to neighboring cells. Shigella is also 
taken up by macrophages, causing their death by pyroptosis and severe inflammation and by neutrophils, which 
kill the bacteria, controlling the infection4.
The Shigella T3SS basal body is anchored in both bacterial membranes and followed by a hollow needle, 
formed of MxiH, that protrudes from the bacterial surface and acts as the secretion channel5–8. The needle is 
capped distally by the tip complex (TC), formed of IpaD and IpaB. The TC was proposed as the host cell sensor 
because without it the bacteria cannot regulate secretion or invade host cells9–13. MxiH, is a ~9 kDa α -helical 
hairpin14,15. It polymerizes into the helical needle using both of its termini15,16. Single amino acid mutations in 
needle proteins alter secretion regulation, host cell sensing and TC composition13,17,18. Similar to MxiH, the 
~37 kDa IpaD contains a central coiled coil and requires its C-terminus to bind needles13,19. Point mutations in 
the upper part of IpaD’s C-terminal helix render the T3SS unresponsive to an artificial inducer of secretion, the 
small amphipathic dye Congo red (CR20) or to host cells21. This and its position atop needles indicate it is involved 
in sensing host cells. IpaD is essential for recruitment of IpaB to TCs13. Only one third of the structure of the 
~62 kDa hydrophobic IpaB was crystallized, as an ~150 amino acid-long antiparallel coiled coil or alacoil22. While 
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Figure 1. Characterization ipaBΔ2-20 and ipaB* mutants. (A) Linear representation of IpaB secondary 
structure predictions and domain assignments. (B) Expression levels of IpaB and IpaC in cultures of S. flexneri 
wild-type (WT), ipaB−, and pDR1 and pUC19::ipaB (complementation plasmids) and ipaBΔ 2-20 in ipaB−.  
(C) Exponential culture supernatants from strains in B were Silver stained (top) or blotted against IpaB 
(bottom). (D) Protein secretion in response to absence (top) or presence (bottom) of CR, analyzed by Silver 
staining. (E) Expression of indicated antigens in cultures of WT, ipaB−, complemented strain (ipaB−/ipaB) and 
ipaB* mutants in ipaB−. (F) Overnight leakage into the culture supernatant of ipaB* and ipaD* 21 mutants in 
ipaB− and ipaD−, respectively, analyzed by Silver staining. (G) Protein secretion of strains in (F) in response to 
CR, analyzed by Silver staining. Colored dots represent degrees of CR induction reduction: strong (blue) and 
mild (green). Results shown are representative of at least two independent experiments. (H) Location of 6 out of 
7 of the IpaB* mutants within the alacoil structure of IpaB (3U0C22). Native amino acids that were mutated are 
shown as stick models.
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IpaB deletion mutants pleiotrophically affect T3SS regulation and host cell invasion23,24, a direct role for IpaB in 
host cell sensing remains uninvestigated.
While others suggest IpaB is added atop needles after exposure to the bile salt deoxycholate (DOC25–27), we 
find IpaB in TCs without DOC addition12,13. Three-dimensional reconstruction of the resting Shigella TC using 
electron microscopy demonstrates a TC subset contains 4 IpaDs and 1 IpaB12. The remainder of TCs at the bacte-
rial surface contain 5 IpaDs, as also reported by other groups28,29. At the helical needle tip, the 11 MxiH protofila-
ments generate 5 subunit-binding sites. Four out of the five potential insertion sites are equivalent but the lowest 
is unique because it is bound by two non-continuously rising subunits11. Five IpaDs may initially polymerize at 
the needle tip, with IpaB then replacing an IpaD at the unique site and protruding above them12. However, it is 
unclear which TCs are functional for sensing.
IpaB binds cholesterol and CD44 in the host cell plasma membrane30,31. Its hydrophobic regions become 
inserted into the host membrane, where it becomes part of the effector translocation pore (translocon), along side 
the hydrophobic IpaC6. IpaB is also involved in T3SS regulation, through transcriptional regulation of some effec-
tors. Indeed, it first sequesters then releases its intrabacterial chaperone, IpgC, upon its own secretion32,33. Free 
IpgC binds MxiE, functioning as transcriptional co-activator of later acting effectors34,35. Finally, IpaB is involved 
in invasion vacuole lysis36,37 and binds caspase-1 to activate macrophage pyroptosis38.
IpaB contains a bipartite chaperone-binding site (residues 16–7239; Fig. 1A). Its N-terminal alacoil region is 
located between residues 74 and 22422 and its IpaC binding domain at residues 367–45840. Between these, IpaB 
carries an amphipathic α -helix (residues 240–280) and a hydrophobic domain (residues 310–430) containing 
two predicted transmembrane helices (residues 313–346 and 400–42341). IpaB is also predicted a C-terminal 
coiled-coil forming α -helix (residues 530–580). Its extreme C-terminus is required for needle binding and secre-
tion regulation23. This would place the IpaB coiled-coil and C-terminal globular domains in a topologically equiv-
alent position to those of IpaD atop TCs, optimally positioning its hydrophobic regions to interact with host cell 
membranes19,23,24.
Prior to contact with cells, TC proteins not already in the tip are cytoplasmically stored32,42. Upon host cell 
sensing, the TC transmits an unknown signal via the needle into the cytoplasm, activating secretion17,43. Given its 
situation in the TC12 and its essential role in host cell membrane penetration and translocon formation6, IpaB is 
likely the host-cell sensor, while IpaD is the first element of the signal transduction cascade13. Activation triggers 
the release of IpaC, forming the translocon in the host membrane along with IpaB atop the TC6,23,24,43, while IpaD 
acts as an adaptor between needle and pore13,44. Translocon insertion triggers a second signal that travels down 
the needle to induce effector secretion17,43.
To summarize, IpaD, IpaB and IpaC are dispensable for secretion, but essential for effector injection in a 
manner that is still not understood. Upstream of this event, IpaD and IpaB are essential for regulation of secre-
tion13,45,46. Cumulative evidence shows the TC is involved in host cell sensing12,13,23,24,43 but this infection-initiating 
event remains mechanistically mysterious. Physical interactions between IpaB, IpaD and the needle tip are central 
to this process12,21,23,24,29. But, how remains unexplored.
To test whether IpaB is directly involved in host sensing, we isolated ipaB mutants unresponsive to activation 
signals. We used a genetic screen for mutants insensitive to induction by CR21. We identified seven ipaB single 
point mutations preventing CR-mediated secretion activation. All but one localized to IpaB’s alacoil. Although 
they all showed normal TC composition some were also impaired in host cell interactions. By combining in cis the 
newly isolated ipaB mutations with a short C-terminal deletion23, we uncovered crosstalk between different IpaB 
regions. Expression of either type of ipaB mutations in trans both with ipaD mutants with similar phenotypes 
and with a constitutively secreting needle mutant17,21 also uncovered epistasis. Overall, we determined which 
regions of IpaB communicate with which in itself, IpaD and MxiH in TCs, and that failures in these interactions 
impair signal transduction. Hence, conformational changes during IpaB membrane-insertion may initiate T3SS 
activation.
Results
Prior to host cell contact, only the Ipa proteins and another early effector are synthesized (i.e., IpaA47, IpaB, IpaC, 
IpaD and IpgD48), with ~5% of these being released slowly via the apparatus. This is termed “leakage”. “Induction” 
is the burst of Ipa protein secretion upon host cell contact45. This may be mimicked by CR addition20, when secre-
tion of 50% of Ipas and IpgD is detected in 15 min. Deregulated leakage, termed “constitutive secretion” involves 
high levels of secretion of Ipa proteins, IpgD and late effectors. Some mxiH mutants lead to “slow” constitutive 
secretion, detectable in hours17. Deletion of ipaD or ipaB leads to “fast” constitutive secretion, detectable in min-
utes, and to CR unresponsiveness13. The physiological relevance of these secretion states is unclear12 but they are 
useful experimental tools and understanding their differences will help follow our results.
IpaB must be secreted to exert its regulatory function. To resolve whether IpaB must be exposed on 
the cell surface to assemble functional TCs, we made an ipaB mutant lacking its first 20 amino acids, predicted to 
contain the secretion signal49. ipaB∆2-20 (Table 1) expressed IpaB at 35% of the level of WT (Fig. 1B), presumably 
because it binds its chaperone with reduced efficiency. We found that expression of below 20% wild-type IpaB lev-
els in ipaB− leads to maximal fast constitutive secretion while 50% of normal IpaB levels greatly reduces it (Fig. S1). 
IpaB∆ 2-20 is not secreted (Fig. 1C, bottom) and ipaB∆2-20 displays fast constitutive secretion and CR unrespon-
siveness, as in ipaB− (Fig. 1C, top and 1D). Hence, ipaB∆2-20 causes maximal constitutive secretion because it 
cannot be secreted, leaving the TC immature and hence dysfunctional.
All but one ipaB mutation unresponsive to CR localize to the alacoil. To assess IpaB’s involve-
ment in sensing the activation signal, we searched for ipaB mutants blocked in secretion activation. For this, we 
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Strain name Genotype Reference
Wild-type Wild-type M90T, serotype 5a 62
SC301 M90T/pIL22, a plasmid encoding the E. coli afimbrial adhesin AFA I 61
SF620 or ipaB− Δ ipaB::aphA-3 mutant 63
SF622 or ipaD− Δ ipaD::aphA-3 mutant 63
SH116 or mxiH− Δ mxiH::aphA-3 mutant 7
ipaB− ipaD− Double mutant Δ ipaB::aphA-3 Δ ipaD::tetRA 21
ipaB−/ipaB or ipaB−/+ ipaB−/pDR1 23
ipaB−/ipaBwt ipaB−/pIMC34 This study
ipaB−/ipaBΔ 2-20 ipaB−/pIMC35 This study
ipaBN85I ipaB−/pIMC24 (isolated from ipaB library) This study
ipaBK93N ipaB−/pIMC5 (isolated from ipaB library) This study
ipaBQ108L ipaB−/pIMA254 (isolated from ipaB library) This study
ipaBN116Y ipaB−/pIMC18 (isolated from ipaB library) This study
ipaBK150E ipaB−/pIMC4 (isolated from ipaB library) This study
ipaBK188E ipaB−/pIMC1 (isolated from ipaB library) This study
ipaBN264I ipaB−/pIMA255 (isolated from ipaB library) This study
ipaBN85I, K93N ipaB−/pIMC40 This study
ipaBQ108L, N116Y ipaB−/pIMC41 This study
ipaBK150E, K188E aka ipaBxx ipaB−/pIMC42 This study
ipaBQ108L, N116Y, K150E aka ipaBxxx ipaB−/pIMC43 This study
ipaBΔ 578-580 aka ipaBc-terΔ 3 ipaB−/pDR2 23
ipaBQ108L, N116Y, K150E, Δ 578-580 aka 
ipaBxxxc-terΔ 3 ipaB
−/pIMC47 This study
ipaD-/ipaD or ipaD−/+ ipaD−/pipaD 44
ipaD-/ipaDK291I ipaD−/pIMA233 21
ipaD-/ipaDQ299I ipaD−/pIMA236 21
ipaB− ipaD−/ipaBN85I ipaB− ipaD−/pIMC24 This study
ipaB− ipaD−/ipaBK93N ipaB− ipaD−/pIMC5 This study
ipaB− ipaD−/ipaBQ108L ipaB− ipaD−/pIMA254 This study
ipaB− ipaD−/ipaBN116Y ipaB− ipaD−/pIMC18 This study
ipaB− ipaD−/ipaBK150E ipaB− ipaD−/pIMC4 This study
ipaB− ipaD−/ipaBK188E ipaB− ipaD−/pIMC1 This study
ipaB− ipaD−/ipaBN264I ipaB− ipaD−/pIMA255 This study
ipaD−/ipaDwt ipaD−/pIMC61 This study
ipaD−/ipaDN186Y, K291I aka ipaDxx ipaD−/pIMC62 This study
ipaD−/ ipaDΔ 330-332 aka ipaDc-terΔ 3 ipaD−/pIMC63 This study
ipaD−/ ipaDN186Y, K291I, Δ 330-332 aka 
ipaDxxc-terΔ 3 ipaD
−/pIMC64 This study
ipaB− ipaD−/ipaBwt ipaB− ipaD−/pIMC51 This study
ipaB− ipaD−/ipaDwt ipaB− ipaD−/pIMA246 This study
ipaB− ipaD−/ipaBwt ipaDwt ipaB− ipaD−/pIMC51 pIMA246 This study
ipaB− ipaD−/ipaBwt ipaDx ipaB− ipaD−/pIMC51 pIMC60 This study
ipaB− ipaD−/ipaBwt ipaDxx ipaB− ipaD−/pIMC51 pIMC58 This study
ipaB− ipaD−/ipaBwt ipaDc-terΔ 3 ipaB− ipaD−/pIMC51 pIMC59 This study
ipaB− ipaD−/ipaBxx ipaDwt ipaB− ipaD−/pIMC57 pIMA246 This study
ipaB− ipaD−/ipaBxx ipaDx ipaB− ipaD−/pIMC57 pIMC60 This study
ipaB− ipaD−/ipaBxxx ipaDwt ipaB− ipaD−/pIMC46 pIMA246 This study
ipaB− ipaD−/ipaBxxx ipaDx ipaB− ipaD−/pIMC46 pIMC60 This study
ipaB− ipaD−/ipaBxxx ipaDxx ipaB− ipaD−/pIMC46 pIMC58 This study
ipaB− ipaD−/ipaBxxx ipaDc-terΔ 3 ipaB− ipaD−/pIMC46 pIMC59 This study
ipaB− ipaD−/ipaBc-terΔ 3 ipaDwt ipaB− ipaD−/pIMC56 pIMA246 This study
ipaB− ipaD−/ipaBc-terΔ 3 ipaDxx ipaB− ipaD−/pIMC56 pIMC58 This study
mxiH−/mxiHQ51A mxiH−/ pmxiHQ51A 15
ipaB− mxiH− Double mutant Δ ipaB:: tetRA Δ mxiH:: aphA-3 43
ipaB− mxiH−/mxiHQ51A ipaB− mxiH−/ pmxiHQ51A This study
ipaB− mxiH−/ ipaBwt mxiHQ51A ipaB− mxiH−/pIMC51 pmxiHQ51A This study
ipaB− mxiH−/ipaBxxx mxiHQ51A ipaB− mxiH−/pIMC46 pmxiHQ51A This study
Continued
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screened a library of ipaB mutants based on their color on plates containing CR. Wild-type Shigella are orange on 
CR plates50. This may reflect secretion of early and late effectors in response to CR. Bacteria lacking functioning 
T3SSs are white51 and those lacking ipaD or ipaB are red46, presumably because they secrete more late effectors.
A library of random ipaB mutants was transformed into ipaB−. Around 1.45 × 106 transformants were 
screened, 241 white clones isolated and 35 white mutants confirmed by sequencing (Materials and Methods; 
Table 1). Some mutations appeared more than once and occasionally more than one mutation was found in ipaB. 
Individual mutations were separated to identify which was responsible for loss of CR-sensing capacity (Table 1). 
Only single point mutations causing the white phenotype, hereafter termed ipaB*, were further investigated.
No ipaB* mutant was altered in its expression (Fig. 1E, top), ability to store and leak others Ipas and IpgD 
(Figs 1E, middle panels and 3F) or to repress expression of the late effector IpaH (Fig. 1E, bottom). However, 
these mutants showed degrees of reduced sensitivity to CR-induction that, for some, was similar to that seen 
for previously characterized CR-insensitive ipaD mutants21 (Fig. 1G; quantified in Fig. S2). All but one muta-
tion (ipaBN264I) localized to IpaB’s alacoil (Fig. 1H). In total, 48% of the independently identified 43 mutations 
sequenced localized to the alacoil (amino acids 74–224), which encompasses only 26% of the protein length. This 
suggests the region is key to secretion initiation. Mutants had strong (ipaBK93N and ipaBN116Y) or mild defects 
in secretion (ipaBN85I, ipaBQ108L, ipaBK150E, ipaBK188E and ipaBN264I) in spite of similar expression levels 
(Fig. 1E, top). Therefore, their phenotype is due to a direct effect of the mutations on IpaB function.
The IpaB* mutants are secreted in a constitutive secretor background. To assess if the ipaB* 
mutations impaired secretion of IpaB, and hence perhaps secretion of the other Ipa/Ipg proteins, we used con-
stitutive secretor ipaD− ipaB− 21. The ipaB* mutants were transformed into this background and their secretion 
profile analyzed by Western blot. IpaB* mutants were expressed and secreted at the same levels as wild-type IpaB 
(Fig. S3A), indicating the newly isolated mutations do not affect IpaB’s ability to be secreted.
Most IpaB* mutants form TCs with normal composition. We next used fluorescence-activated cell 
sorting (FACS) to assess the overall composition of TCs of individual ipaB* mutant cells by immunolabeling 
the surface of fixed bacteria. The specificity of the antibodies was verified by immunofluorescence (Fig. S4). As 
negative controls we used mxiH−, ipaB− and ipaD−, which cannot form needles and/or TCs7. As expected ipaB−, 
ipaD−, ipaB− ipaD− and mxiH− showed no/very reduced IpaB staining. Six out of seven ipaB* mutants showed 
normal TC composition. ipaBN264I showed a slightly higher average amount of IpaB at the bacterial surface 
(statistically significant at p = 0.05 but not at p = 0.02) although it did not show any change in the amount of IpaD 
(Fig. 2A). Thus, the number of needles and TCs it carries is same as in WT. Therefore, ipaBN264I could affect the 
accessibility of this mutant IpaB to the antibodies used for FACS, perhaps reflecting its altered conformation in 
TCs. The data above indicate all IpaB* mutants localize to TCs. Therefore, isolation of CR-insensitive ipaB point 
mutants suggests IpaB is directly involved in mediating CR responsiveness.
Some ipaB* mutants form translocons poorly. As IpaB’s membrane-insertion is necessary for epithe-
lial cell invasion, we studied the effect of the ipaB* mutations on pore formation using contact hemolysis. Indeed, 
Shigella lyses Red Blood Cells (RBCs) upon physical contact with them6, due to membrane insertion of IpaB 
and IpaC, which form a pore within RBC membranes6. ipaB−/+ and WT showed 85–80% of detergent-mediated 
hemoglobin release, which is set as 100% hemolysis in this assay (Fig. 3A). Some mutants had normal hemo-
lytic capacity (ipaBK93N, ipaBN116Y, ipaBK150E, ipaBK188E), others showed only 60–30% of total hemolysis 
(ipaBN85I and ipaBQ108L), while ipaBN264I had none. Mutants with the strongest unresponsiveness to CR 
(ipaBK93N, ipaBN116Y) displayed hemolytic activities similar to WT. Thus, the ability to respond to CR is genet-
ically dissociable from the ability to perform hemolysis.
Was the decrease in hemolytic activity of some ipaB* mutants due to a problem in membrane-insertion of 
mutant IpaB? For those mutants with reduced hemolytic activity, we examined the composition of the lysed RBC 
membranes isolated by floatation in a sucrose density gradient. We also studied ipaBN116Y as the mutant with 
the greatest reduction in CR induction. Since functional IpaB is a prerequisite for membrane insertion of IpaC6, 
no IpaB and little IpaC were detected in RBCs exposed to ipaB− (Fig. 3B). In the membrane fractions of RBCs 
incubated with ipaBN85I and ipaBN116Y, the amount of IpaB was less (48% ± 16 and 58% ± 25 reduction relative 
to ipaB−/+, respectively; Fig. S3B). For ipaBQ108L, the amount of IpaB detected was even less (75% ± 4 reduc-
tion). Mutant ipaBN264I showed little IpaB (94% ± 2 reduction) associated with RBC membranes. All mutants 
showed proportional reductions in IpaC insertion (Figs 3B and S3B). N264 is found in the amphipathic α -helix 
Strain name Genotype Reference
ipaB− mxiH−/ ipaBc-terΔ 3 mxiHQ51A ipaB− mxiH−/pIMC56 pmxiHQ51A This study
ipaD− mxiH− Double mutant Δ ipaD:: tetRA Δ mxiH:: aphA-3 12
a
ipaD− mxiH−/mxiHQ51A ipaD− mxiH−/pmxiHQ51A This study
ipaD− mxiH−/ipaDwt mxiHQ51A ipaD− mxiH−/pIMA246 pmxiHQ51A This study
ipaD− mxiH−/ipaDxx mxiHQ51A ipaD− mxiH−/pIMC58 pmxiHQ51A This study
ipaD− mxiH−/ipaDc-terΔ 3 mxiHQ51A ipaD− mxiH−/pIMC59 pmxiHQ51A This study
Table 1.  Bacterial strains used in this study. aWe have noticed that all strains made with this background 
express less, and hence secrete little IpaA. This may be due to the manner in which ipaD, which lies directly 
upstream of ipaA, was inactivated in them. However, this has no bearing on the study described here.
www.nature.com/scientificreports/
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Figure 2. Analysis of IpaB, IpaD and MxiH at the Shigella surface by FACS. Strains were analyzed using 
antibodies against IpaB, IpaD and MxiH. (A) Percent brightness of ipaB−, ipaD−, mxiH−, ipaB− ipaD−, 
complemented strain (ipaBwt) and ipaB mutants in ipaB−. Colored dots represent degrees of CR induction 
reduction, as in Fig. 1G. (B) In cis combination of ipaB and ipaD mutations in ipaB− and ipaD−, respectively. 
For ipaB mutant strains, results shown are representative of two independent experiments. (C) In trans 
combination of ipaB and ipaD mutations in ipaB− ipaD−. Mutants were compared to ipaBwt ipaDwt.  
www.nature.com/scientificreports/
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of IpaB (Fig. 1A), which is important for interaction with lipids vesicles52. Its polar side chain seems required for 
interaction with lipid bilayers.
There is little correlation between the ipaB* mutants’ abilities to sense CR and invade host cells. 
To evaluate ability of the mutants to invade epithelial cells, we measured protection from Gentamicin upon entry 
into HeLa cells, since this antibiotic cannot penetrate host cells. ipaBN85I and ipaBQ108L did not complement 
ipaB− for cell invasion efficiently and ipaBN264I failed to restore invasion (Fig. 3C). Thus, there is fairly good 
correlation between the capacities of the mutants to perform hemolysis and invasion. In contrast, some showed 
strong defects in CR responsiveness but were unaffected in hemolysis and invasion (ipaBK93N and ipaBN116Y). 
This indicates that their capacities to sense CR and host cells are dissociable genetically.
Combinations of ipaB* mutations enhance CR unresponsiveness. To assess whether the IpaB ala-
coil folds in vivo as it does in the crystal structure, we combined mutations within amino acids nearby in the 
structure (Fig. 1H) to investigate whether their combination produces stronger phenotypes.
While all combinations of mutants formed had normal TC composition (Fig. 2A), ipaBN85I, K93N and 
ipaBK150E, K188E (termed ipaBxx from now on) showed slightly enhanced inability to respond to CR relative 
to each single mutant whereas for ipaBQ108L, N116Y the enhancement was greater (Fig. 3D,E). ipaBQ108L, 
N116Y, K150E (hereafter termed ipaBxxx) showed a slight, if reproducible, reduction in leakage and complete 
uninducibility. Since in ipaBxxx the altered amino acids are far apart, the stronger phenotypes are likely not due 
to the amino acids co-assessed being close in the structure. However, that some IpaB* mutations enhance others 
suggests they produce incremental, structurally-related effects.
Given the lack of correlation between CR-sensitivity and host cell sensing ability in ipaB* mutants, is there 
any correlation between these phenomena for IpaB? To answer this, we tested the invasive capacity of ipaBxx and 
ipaBxxx (Fig. S5). Unsurprisingly given that ipaBQ108L is non-invasive, ipaBxxx is also. More informatively, 
ipaBxx is also non-invasive, when both ipaBK150E and ipaBK188E are WT-like for invasion. Thus, several muta-
tions in IpaB’s alacoil region, especially when combined, do affect host cell sensing. This suggests the alacoil is 
involved in transmission of both the CR and host-cell sensing signals. However, it seems less sensitive to the latter.
There is intramolecular crosstalk between IpaB regions. Could we alter the combined ipaB* mutant’s 
secretion phenotypes? In ipaBc-terΔ 3, IpaB is expressed lacking its last three C-terminal amino acids, making the 
T3SS constitutively active and weakly inducible by CR23. Hence, we examined if the secretion patterns of ipaBxxx 
are altered when expressed in an ipaBc-terΔ 3 background. This combined mutant showed a new, intermediate 
phenotype: reduced constitutive secretion and reduced CR-induction relative to ipaBc-terΔ 3 (Fig. 4A,B, left , C). 
This indicates epistasis between these sets of mutations, suggesting intramolecular crosstalk between these IpaB 
domains, where the alacoil region acts upstream of the C-terminus.
Dual modification of IpaD’s C-terminus leads to loss of needle tip binding. We previously iso-
lated ipaD mutants with decreased CR responsiveness21 and others characterized ipaDΔ 330-332, termed here 
ipaDc-terΔ 3, as a constitutive secretor29. To assess the effect of combinations of these mutations on IpaD, the 
other TC component, we combined ipaDN186I, K291I (ipaDxx21), an ipaD* mutant with strongly reduced 
secretion, in cis with ipaDc-terΔ 3. Contrary to what happened in ipaBxxx_c-terΔ 3, ipaDxx had no effect on 
ipaDc-terΔ 3 (Fig. 4A,B, right, D): ipaDxx_c-terΔ 3 behaved as a constitutive secretor. However, all mutants 
expressed similar Ipa/Ipg levels (Fig. 4B), ruling out deleterious decreases in protein expression.
To understand these contrasting results, we assessed the TC composition of these mutants by FACS (Fig. 2B). 
ipaBxxx, ipaBc-terΔ 3 and ipaBxxx_c-terΔ 3 have the same tip composition as ipaB−/+. However, ipaDxx_c-terΔ 
3 displays a strong decrease in IpaD (and hence IpaB) when compared with ipaDxx and ipaDc-terΔ 3. Thus, 
IpaDxx_c-terΔ 3 can not bind the needle tip. This may be due to localization of N186 and K291 near or within 
the C-terminal helix of IpaD. As TC composition is wild type-like for ipaDxx and ipaDc-ter∆3 mutants, this also 
suggests they are affected in signaling from the needle tip and not a downstream step.
In trans combination of CR-insensitive ipaB or ipaD mutants and C-terminal deletions gener-
ates new phenotypes. To assess whether IpaB and IpaD communicate within the TC, we constructed a 
series of ipaB and ipaD mutants in trans, which we transformed into ipaB− ipaD−. To reveal phenotypic changes, 
we combined mutants showing mild phenotypes, ipaBxx and ipaDK291E (ipaDx) with others displaying strongly 
impaired secretion, ipaBxxx and ipaDxx. We also combined these mutants with mutants exhibiting constitutive 
secretion (ipaBc-terΔ 3, ipaDc-terΔ 3).
To compare the overall phenotype of all mutants, we plated them on CR plates with and without IPTG, which 
they need for ipaD expression (Fig. S6). Without IPTG, all strains were red due to absence of TCs and constitu-
tive secretion, verifying they all made T3SSs. With IPTG, ipaDwt ipaBwt was orange, as expected for wild-type. 
All combinations of ipaB* and ipaD* mutants were white, indicating intact, CR-insensitive TCs and suggesting 
(D) Combination of ipaB or ipaD and mxiHQ51A mutations in ipaB− mxiH− or ipaD− mxiH−, respectively. 
Mutants were compared against strains ipaBwt mxiHQ51A or ipaDwt mxiHQ51A. Single mutants were 
compared to WT. Values derive from ≥ 2 × 105 events per sample. Values were normalized against WT after 
subtraction of background and compared against corresponding complemented strains. Data presented are the 
arithmetic mean of the geometric means from, unless otherwise stated, at least three independent experiments. 
Standard deviations of the means are indicated with bars. Asterisks indicate statistically significant differences 
(p ≤ 0.02) between samples, calculated with Student’s t test (type 3 (A,C), type 2 (B,D)) after ANOVA.
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synergy between these mutations. In addition, all combinations of ipaB* or ipaD* mutants with ipaDc-terΔ 3 or 
ipaBc-terΔ 3 mutants were orange to red, suggesting at best partial suppression of the constitutive secretion of 
ipaDc-terΔ 3 or ipaBc-terΔ 3.
We next verified expression IpaB, IpaC and IpaD in these strains was similar to WT (Fig. 5D). We also assessed 
the levels of IpgD and IpaH. Indeed, the more the T3SS secretes, the higher the expression of IpaH and, to some 
Figure 3. Analysis of ipaB* single mutants host-cell interaction properties and of secretion phenotypes 
of combinations of ipaB* mutants. (A) Hemolytic activity of ipaB* mutants. Values were normalized against 
those obtained with detergent addition after subtraction of background from RBCs incubated in PBS. Data 
are averages from ≥ 3 experiments performed in triplicate; error bars indicate standard deviations. Asterisks 
indicate statistically significant differences (p < 0.05) between samples compared against the complemented 
strain, calculated with Student’s t Test (type 3) after ANOVA. (B) Association of IpaB and IpaC from 
selected ipaB* mutants with RBC membranes. Samples were normalized by protein concentration. Figure is 
representative of three experiments. (C) HeLa cell invasion by ipaB* mutants. Experiments were normalized 
against WT. Data represent the mean of ≥ 3 independent experiments performed in triplicate; error bars 
indicate standard deviations. Asterisks indicate statistically significant difference (p ≤ 0.05), assessed as above. 
Colored dots represent degrees of CR induction reduction, as in Fig. 1G. (D) Overnight leakage of WT, ipaB−, 
ipaB−/ipaB and ipaB* mutants in ipaB−. (E) Their protein secretion in response to CR. (F) Protein expression 
levels in their cultures. Samples were Silver stained (D,E) or blotted with indicated antibodies (F). Results 
shown are representative of ≥ 2 independent experiments.
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Figure 4. Characterization of in cis combined ipaB or ipaD mutants. Combinations of ipaB* mutations and 
an IpaB C-terminal truncation in ipaB− (left) and of similar IpaD mutations in ipaD− (right) were studied.  
(A) Overnight leakage of indicated strains, analyzed by Silver staining. (B) Expression levels of the translocators 
in total cultures, analyzed by blotting. The images shown are from the same experiment but irrelevant 
intervening lanes were removed. (C,D) Proteins secreted in response to CR, analyzed by Silver staining. Results 
shown are representative of at least two independent experiments.
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Figure 5. Characterization of in trans combined ipaB or ipaD mutants. Combinations of ipaB* mutations 
and an IpaD C-terminal truncation, or vice versa, were studied in ipaB− ipaD−, grown with 30 μ M IPTG.  
(A) Exponential leakage. Protein secretion in response to absence (B) or presence (C) of CR. (D) Protein 
expression levels of translocators IpaB, IpaC and IpaD and late effectors IpaH and IpgD. Samples analyzed by 
Silver staining (A–C) or Western-blotted with the indicated antibodies (D). Results shown are representative of 
at least two independent experiments.
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extent, also of IpgD. The increased levels of IpgD and IpaH expression confirmed that, all combination of ipaD* 
or ipaB* mutants with ipaBc-terΔ 3 or ipaDc-terΔ 3, respectively, were constitutive secretors.
No difference was observed in the TC composition of these mutants but one, ipaBxxx ipaDc-terΔ 3 (Fig. 2C). 
Despite normal levels of IpaDc-terΔ 3, it had lower levels of surface-localized IpaBxxx. Both ipaBc-terΔ 3 ipaDwt 
and ipaBc-terΔ 3 ipaDxx, show similar levels of IpaB but higher, if not significantly different, levels of IpaD.
Those “* ” mutants that individually showed normal leakage, when combined with “* ” or WT partners 
were confirmed to display the same phenotype and the same mutants in combination with constitutive secre-
tors (ipaBc-terΔ 3 & ipaDc-terΔ 3) to display constitutive secretion. Thus, in ipaBc-terΔ 3 ipaDxx, contrary to 
what happened in ipaBxxx_c-terΔ 3, ipaDxx did not attenuate constitutive secretion of ipaBc-terΔ 3, although it 
formed compositionally normal tips (Fig. 5A, lane 14 from left). When ipaBxxx was combined with ipaDc-terΔ 
3 (Fig. 5A, lane 13) a constitutive secretor phenotype was also observed, due to lack of IpaBxxx and presence of 
ipaDc-terΔ 3 in TCs. These data indicate a C-terminal deletion in IpaB bypasses the repressing effects of ipaD* 
mutations on secretion activation. This suggests IpaB’s C-terminus acts downstream of the upper part of the IpaD 
C-terminal helix. Furthermore, by comparison with the partial suppression of constitutive secretion seen with 
IpaBxxx_cterΔ 3, lack of suppression of ipaBc-terΔ 3 by ipaDxx suggests the globular domain of each protein can 
signal independently, via its own C-terminus.
Combination of mutants showing mild reductions in inducible secretion, ipaBxx and ipaDx, resulted in 
decreased CR-inducibility (Fig. 5B,C, lanes 8 and 9), whilst the combination of ipaBxxx with ipaDx resulted in 
abrogation of the latter’s inducibility (Fig. 5C, lanes 10 and 11). The combination of ipaBxxx and ipaDxx in trans 
did not enhance their already strong phenotypes (Fig. 5C, lane 12). Thus, mild IpaB* and IpaD* mutations are syn-
ergistic. These data, together with our TC reconstruction where IpaD and IpaB are juxtaposed12, support intermo-
lecular communication between their globular regions during secretion activation. Finally, when the constitutive 
secretor ipaBc-terΔ 3 was co-expressed with ipaDxx, another new phenotype was observed (Fig. 5B,C, lane 15): 
fast constitutive secretion as in ipaBc-terΔ 3 (Fig. 5A) but as little CR-responsiveness as in ipaDxx (Fig. 5B,C). 
This suggests intermolecular crosstalk between the globular regions and the C-termini of these two molecules 
during CR sensing.
For ipaBxxx ipaDc-terΔ 3, in spite of the constitutive secretion described above, including of IpaD, we 
observed a reduction in the level of IpaD secreted without or without CR as compared to ipaBwt ipaDc-terΔ 3 
(Fig. 5B,C, lane 13). This was verified by western blotting (Fig. S7A). This indicates that IpaBxxx uniquely affects 
fast secretion of IpaDc-terΔ 3.
The activation signal travels from IpaB and IpaD to the needle. To examine how IpaB and IpaD 
interact with the needle component MxiH, we combined ipaBxxx, ipaDxx, ipaBc-terΔ 3 and ipaDc-terΔ 3 with 
slow constitutive secretor mutant mxiHQ51A17. This mutation is located in MxiH’s “head”, i.e. at the very top of the 
needle, where the C-termini of IpaD and IpaB probably interact MxiH12. Using FACS, we titrated the IPTG con-
centration necessary to obtain wild-type levels of IpaB, IpaD and MxiH in the mxiHQ51A background (Fig. S8). 
Then we confirmed the expression of IpaB, IpaC and IpaD in these strains was similar to WT (Fig. 6). We also 
assessed the expression of IpgD and IpaH.
ipaB− and ipaD− showed more IpaD and MxiH surface staining, respectively, by FACS (Fig. 2D). As neither 
ipaB− nor ipaD− show longer needles6, we investigated whether these mutants upregulate the number of T3SSs 
and hence TCs they express using electron microscopy analysis of negatively stained, osmotically shocked cells, 
as previously established17. We visualized 0.8 ± 1.3 (n = 14), 2.5 ± 2.3 (n = 19) and 3.7 ± 2.7 (n = 27) T3SS basal 
bodies on the periphery of WT, ipaB− and ipaD− cells, respectively. Therefore, as demonstrated by a Student’s test 
after ANOVA, ipaB− and ipaD− possess similar number of basal bodies but both possess significantly more than 
wild-type (p = 0.0162 and 0.0004, respectively). This suggests that the fast constitutive secretion state leads to a 
3–4 fold increase the number of T3SS basal bodies. In addition, mxiHQ51A showed a reduction in IpaB surface 
staining relative to wild-type. This was not previously observed12,13, but might contribute to increased leakage in 
this mutant. In a mxiHQ51A background, ipaBc-terΔ 3 and ipaDc-terΔ 3 showed a significant absence of IpaB, 
but not of IpaD (Fig. 2D). However, in a mxiHwt background these two mutants show normal TC composition 
(Fig. 2B). This indicates short C-terminal deletions in IpaDc-terΔ 3 or IpaBc-terΔ 3 adversely affect IpaB’s inter-
action with MxiH with a point mutation in its head. Finally, in a mxiHQ51A background, ipaBxxx showed slightly 
higher (significant at p = 0.05 but not at p = 0.02) and ipaDxx showed higher levels of IpaB surface staining, 
respectively, suggesting these mutations stabilize IpaB at the TC. These data indicate the IpaB C-terminus inter-
acts with MxiHQ51 and this is affected by mutations in the alacoil and in the C-terminus of IpaD.
No expression of IpaH was detected in mxiHQ51A whole cell extract although this mutant is a slow constitu-
tive secretor (Fig. 6C). This suggests the level of constitutive secretion in mxiHQ51A is not strong enough to acti-
vate ipaH transcription. Furthermore, ipaB−, ipaBc-terΔ 3, ipaD− and ipaDc-terΔ 3 when each combined in trans 
with mxiHQ51A show similarly increased levels of IpgD and IpaH, confirming their fast constitutive secretion.
As expected from their tip composition, ipaBc-terΔ 3 and ipaDc-terΔ 3 displayed constitutive secretor phe-
notypes when combined with mxiHQ51A (Fig. 6A left and right panels). However, for ipaDc-terΔ 3 this level was 
higher than in ipaDwt. In ipaDc-terΔ 3 mxiHQ51A, IpaB is lost from TCs whereas both proteins are still present 
intracellularly, again suggesting the former is the cause of fast constitutive secretion. The differing levels of leakage 
(Fig. 6A,C, top row) displayed by mxiH−/mxiHQ51A versus mxiH− ipaB−/mxiHQ51A ipaBwt indicate that in the 
latter, complementation by ipaB is only partial (Fig. 6A, left, lanes 4–6), perhaps because its expression level is lower 
than in the former (Fig. 6C, lanes 5–7). However, ipaBxxx suppresses the leakage seen in mxiH− ipaB−/mxiHQ51A 
ipaBwt (Fig. 6A, left, lanes 7). Full complementation occurred in mxiH− ipaD−/mxiHQ51A ipaDwt (Fig. 6A, 
right, lanes 4–6) and suppression of leakage by ipaDxx was also seen. That ipaBxxx and ipaDxx both stabilize IpaB 
in the TC in an mxiHQ51A background (Fig. 2D) may explain the leakage reduction. Both ipaBxxx and ipaDxx 
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Figure 6. Analysis of combinations of ipaB or ipaD signaling mutants with mxiHQ51A. ipaB and ipaD 
mutant strains were grown with 20 μ M IPTG and mxiH−/mxiHQ51A was grown in 25 μ M IPTG.  
(A) Exponential leakage of indicated strains compared with WT, ipaB−, ipaD− and mxiH−. (B) Protein 
secretion in response to CR of ipaB (left) and ipaD (right) mutants. (C) Expression levels of translocators IpaB, 
IpaC and IpaD and late effectors IpaH and IpgD. Samples were Silver stained (A,B) or blotted with the indicated 
antibodies (C). Results shown are representative of at least two independent experiments.
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Figure 7. Schematic summary table of phenotypes of key mutants studied. Illustration of the effect of ipaB 
and ipaD mutations on the phenotype of the studied and/or newly constructed strains. The term “Color” is 
based in the colony color displayed when grown on TCS agar supplemented with 100 μ g/ml CR (as in Fig. S6). 
Leakage and inducibility have been represented according to the phenotypes shown in Silver stained gels of 
exponential leakage and protein secretion under CR induction (Figs 1 and 3–6). Finally, tip composition has 
been drawn in accordance with FACS results (Fig. 2).
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suppress mxiHQ51A more strongly under inducible conditions (Fig. 6B, both sides, lanes 9–12). This indicates that 
IpaD and IpaB signal to MxiH, initially via their globular domains.
Under non-induced conditions ipaBc-terΔ 3 mxiHQ51A released IpaC and IpaD in normal amounts, but not 
IpaB (Fig. S7B), although IpaB is secreted in ipaBc-terΔ 323. In addition ipaDxx mxiHQ51A could leak IpaD but 
not secrete it inducibly (compare Fig. 6A, right, lane 7 to 6B, right, lanes 10 & 12). Together with the data showing 
that ipaBxxx affects secretion of IpaDc-terΔ 3, this suggests IpaB and IpaD can sense each other’s status in the TC 
and regulate aspects of their secretion.
All ipaB and ipaD mutations studied are epistatic over mxiHQ51A in that they change TC composition and/
or affect aspects of secretion regulation. Given their location atop needles12, this demonstrates both proteins 
regulate secretion upstream of the needle, i.e. from the TC. Our overall results, summarized in Fig. 7, now better 
mechanistic understanding of the TC’s intriguing functionalities.
Discussion
IpaB is involved in sensing the secretion activation signal at the needle tip. All ipaB* mutants 
are partially defective in CR-sensing although they show normal TC composition. Furthermore, they are stably 
expressed, able to prevent premature secretion and do not have intrinsic secretion defects. IpaB∆ 2-20’s cytoplas-
mic sequestration provokes maximal constitutive secretion and uninducibility. There is presently no evidence that 
IpaB exerts any direct regulatory function inside the bacterium, although its secretion is signaled by its “empty” 
chaperone. This is supported by the phenotype of ipaBc-terΔ 3, which has a normal N-terminus but is still a 
constitutive secreter because of its needle interaction defect. Short C-terminal truncations in IpaB may alter its 
conformation at needle tips, leading to constitutive secretion with some inducibility21. Thus, IpaB’s presence at the 
tip is essential for T3SS regulation and inducibility. Therefore, 1) our IpaB* mutants are acting from the TC and 2) 
TCs containing only pentameric IpaD are a secretion-deregulated assembly intermediate that exists prior to IpaB 
recruitment or due to the temporary loss of the hydrophobic IpaB from the needle tip12.
Some combinations of ipaB* mutants display additive phenotypes. The triple mutant ipaBxxx abrogates 
inducibility although it is stably at the tip. The fast constitutive secretor and partially inducible phenotype of 
ipaBc-terΔ 3 was reduced by in cis addition of ipaBxxx. These two sets of mutations are in different regions but, 
when localized in the same molecule, they alter each other’s effect. Observations of synergism and epistasis sup-
port the notion that the activation signal travels within IpaB.
IpaB’s involvement in events beyond host cell sensing. All previously published ipaB mutants carry 
substantial deletions, leading to pleiotrophic effects23,24,41. Here, we used an unbiased method to obtain single 
mutations, focusing on IpaB’s role in secretion regulation. Selected mutants were also used to analyze IpaB’s 
interaction with eukaryotic cells. ipaBN264I is strongly impaired in hemolysis and invasion because it is unable to 
insert IpaB and IpaC in RBC membranes. ipaBQ108L also displays substantial reductions in membrane-inserted 
IpaB and IpaC. In contrast, ipaBN116Y shows no reduction in hemolysis or invasion although it displays less 
membrane-inserted IpaB and IpaC. Why the latter two mutants are affected in these steps is not clear. ipaBN85I 
is mildly affected in CR-sensitivity, hemolysis and translocon insertion but to a greater extent in invasion. This 
mutant might thus be defective in events after translocon insertion, such as effector release17,53.
Role of IpaB’s alacoil in signal transduction. All but one ipaB* mutation are located in its alacoil22. In 
this region, IpaB and its Salmonella SPI1 T3SS homolog SipB show structural similarity with the receptor-binding 
domain of E2, E3/E9 and Ia colicins22. Colicins are secreted by some strains of Escherichia coli and lethal for 
others54. The colicin sequence similarity does not extend into the amphipathic helix and two transmembrane 
regions of the IpaB family, although the topologically equivalent portion of pore-forming colicins (such as Ia) has 
similar features. These hydrophobic features are shared too with the Bcl-2 family of apoptosis regulators55 and 
with the membrane insertion domains of diphtheria toxin56, which both also form membrane pores. Recently, the 
structure of central region of an IpaB homolog from Aeromonas, was solved in combination with its chaperone. 
AopB’s fold is very reminiscent of the hydrophobic region of pore-forming colicins and Bcl-2 proteins, with the 
hydrophilic and amphipathic helices wrapping around and shielding the hydrophobic ones57. This suggests IpaB/
SipB adapted mechanisms used by pore-forming toxins to insert into membranes.
The colicin E9 alacoil region opens up for it to insert into target membranes58. Perhaps IpaB also “opens up” 
upon insertion of its hydrophobic regions into host membranes, thus initiating the signaling cascade (Fig. S9)? 
The clustered location of our “* ” mutants within the alacoil and their synergistic effects suggest conformational 
changes in this region trigger secretion activation. However, if preventing such an alteration were how our new 
CR-insensitive mutations act, the IpaB* mutants should to be unable to sense host cells as well. More likely there-
fore, and in view of their synergism with our IpaD* mutants, the mutations render the IpaB-IpaD interface more 
resistant to disruption by CR, whilst the host cell is sensed differently. Given IpaB’s physically distal position in 
the TC, this may occur through IpaB alone, initially via an area other than its alacoil. However, the signal would 
be transduced through the alacoil and via IpaD since ipaBxx and ipaD* mutants are largely insensitive to host 
cells. ipaBN264I, in the amphipathic helix, impairs insertion of IpaB in host membranes and is also partially 
CR-insensitive. It therefore highlights a connection between changes in the amphipathic helix, which lies par-
allel to the membrane in liposome-inserted IpaB52,59, and signal transmission via the alacoil, where the other 
CR-insensitive mutations map.
Directionalities for signal transduction. Single amino acid substitutions in IpaB deregulate secretion 
activation. Combining deregulated mutants demonstrated intramolecular communication within IpaB (Figs 3D,F 
and 4) and intermolecular communication between TC components (Fig. 5). Moreover, ipaBxxx and ipaDxx both 
suppress mxiHQ51A constitutive secretion (Fig. 6). This indicates IpaB and IpaD act in the same pathway and 
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via MxiH to regulate secretion activation. Considering TC morphology12, we conclude IpaB is the major host cell 
sensor while IpaD works it with to transmit the activation signal down the needle.
How is the signal transmitted down the TC to the needle? Localization of our IpaB mutations to the amphip-
athic helix and alacoil suggests these regions act coordinately. We uncovered further crosstalk between different 
regions of IpaB by combining ipaB* alacoil mutations in cis with some in the IpaB C-terminus23. IpaB-IpaD, 
IpaB-MxiH, IpaD-MxiH (this study and28,29) and MxiH-MxiH17 interactions are all important. IpaD-IpaD inter-
actions are difficult to probe. Without an atomic resolution model for the TC and needle, the mechanism of this 
signal transduction event is unapproachable in further detail.
Methods
Bacterial strains and culture. Bacterial strains and plasmids used are listed in Tables 1 and 2. Shigella flex-
neri strains were maintained on Congo red (CR, 100 μ g/ml; Serva) agar plates and grown at 37 °C in Trypticase 
Soy Broth (Becton Dickinson) supplemented with antibiotics when necessary (100 μ g/ml ampicillin, 50 μ g/ml 
kanamycin, 10–20 μ g/ml chloramphenicol, 5 μ g/ml tetracycline). IPTG and arabinose were used at the concen-
trations indicated in the figure legends.
Construction of ipaBΔ2-20. PCR site-directed mutagenesis using pDR123 as a template was carried out 
with Pfx Platinum polymerase (Invitrogen). ipaB was amplified using forward primers 1 and 2 (Table 3) to create 
Plasmid Description Reference
pDR1 pUC19::ipaB 23
pDR2 pDR1::ipaBΔ 578-580 aka ipaBΔ 3 23
pIMA254 pDR1::ipaBQ108L This study
pIMA255 pDR1::ipaBN264I This study
pIMC34 pUC19::ipaB (no8aa extras and RBSbad) This study
pIMC35 pIMC34::ipaBΔ 2-20 This study
pIMC1 pDR1::ipaBK188E This study
pIMC4 pDR1::ipaBK150E This study
pIMC5 pDR1::ipaBK93N This study
pIMC18 pDR1::ipaBN116Y This study
pIMC24 pDR1::ipaBN85I This study
pIMC40 pDR1::ipaBN85I, K93N This study
pIMC41 pDR1::ipaBQ108L, N116Y This study
pIMC42 pDR1::ipaBK150E, K188E This study
pIMC43 pDR1::ipaBQ108L, N116Y, K150E This study
pUC18_oc Modified pUC18 insensitive to LacI 12
pDR6_oc pUC18_oc::ipaDC322S 12
pIMC46 pUC18_oc::ipaBQ108L, N116Y, K150E This study
pIMC47 pDR1::ipaBQ108L, N116Y, K150E, Δ 578-580 This study
pIMC49 pUC18::ipaDΔ 330-332 This study
pIMC51 pUC18_oc::ipaBwt This study
pIMC56 pUC18_oc::ipaB Δ 578-580 This study




pIMA237 pUC18::ipaDN186Y, K291I 21
pIMA246 pIMA246::ipaDwt This study
pIMC58 pIMA246::ipaDN186Y, K291I This study
pIMC59 pIMA246::ipaDΔ 330-332 This study
pIMC60 pIMA246::ipaDK291I This study
pIMC61 pUC18_oc::ipaD This study
pIMC62 pUC18_oc::ipaDN186Y, K291I This study
pIMC63 pUC18_oc::ipaDΔ 330-332 This study
pIMC64 pUC18_oc::ipaDN186Y, K291I, Δ 330-332 This study
pmxiHQ51A pACT3::mxiHQ51A 15
pIMC30 pBAD_myc_HisA::ipaB This study
Table 2.  Plasmids used in this study.
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ipaBwt and ipaBΔ 2-20, respectively. Primer 5 was used as reverse primer. After digestion with HindIII and PstI, 
fragments were cloned into pUC19, thereby removing eight additional N-terminal amino acids introduced 
by earlier subcloning60 that could have an undesirable effect on the signal peptide and giving rise to plasmids 
pIMC34 and pIMC35. This vector had the same levels of IpaB expression as pDR1, which also yields functional 
IpaB protein60 and which was previously used to isolate the point mutants below.
To assess the level of IpaB necessary for complementation a new plasmid was constructed where ipaB was 
placed under the control of an arabinose inducible promoter, giving rise to pIMC30. We used pBAD_myc_His 
cut by NcoI and PstI to clone ipaB amplified by PCR with primers 4 and 18.
Construction of the ipaB mutant libraries. PCR mutagenesis was carried out with Taq DNA polymer-
ase (New England Biolabs) using error prone reaction conditions (3 mM and 4 mM Mg2+), primers 3 and 4 and 
pDR1 as template. PCR fragments were purified, digested with HindIII and PstI and ligated into plasmid pDR123. 
Ligation mixtures were electroporated into E. coli DH5α carrying an empty pACT3 to produce LacI and repress 
otherwise toxic ipaB expression or into XL2 for the same reason. Transformations were incubated for 16h at 37 °C, 
plasmid DNA was then extracted and kept at − 20 °C.
Screening of ipaB mutant libraries. To identify non-inducible mutants, DNA from each mutant library 
was electroporated into ipaB− (red colony) and screened for white colonies on TCS agar plates containing 100 μ g/ml 
CR. Putative ‘white’ colonies were selected, their plasmids isolated and retransformed into the ipaB− mutant to 
ensure the white color was not due to loss-of-function mutations elsewhere within the T3SS-encoding operons. 
Candidate plasmids were sequenced to identify the mutation(s) responsible for the mutant phenotype (Table 2).
Combination of double and triple ipaB mutants. We constructed the new mutants using two-step PCR 
followed by fragment purification, digestion with HindIII and SpeI and subsequent cloning into digested pDR1. 
As mutations in pIMC40 (ipaBN85I, K93N) and pIMC41 (ipaBQ108L, N116Y) are close they were introduced 
together in the PCR primers. The first step of PCR consisted in two reactions, one reaction used primers 3 and 6 
and second reaction primers 5 and 7 for pIMC40, where primers 6 and 7 overlap and contain the mutation, and 
pairs 3 and 9 and 5 and 8 for pIMC41, where primers 8 and 9 overlap and contain the mutation; pDR1 was used 
as template. The two PCR fragments were used as a template for the second step PCR, which was performed using 
primers 3 and 5 for both pIMC40 and pIMC41.
For pIMC42 (ipaBK150E, K188E), as both mutations are farther apart, mutation K188E was introduced by 
two-step PCR into pIMC4 already encoding K150E. The first step PCR was carried out with primer pair 3 and 
11 and primer pair 5 and 10. The second step was as for pIMC40 and pIMC41, with primers 3 and 5. The triple 
mutant pIMC43 (ipaBQ108L, N116Y, K150E) was constructed as for pIMC41 but using pIMC4 as template.
ipaBxx, ipaBxxx, and ipaBwt were later introduced into pUC18_oc plasmid12, which is insensitive to LacI, to 
combine them in trans with the IPTG inducible plasmid pACT3. The ipaB mutants were amplified by PCR using 
primers 12 and 13, using pDR1, pIMC42 and pIMC43 as templates. PCR fragments were then digested with NdeI 
and BamHI and cloned into pUC18_oc given rise to plasmids pIMC46, pIMC51 and pIMC57.
Construction of truncated ipaBΔ3 and ipaDΔ3 and derivatives. We cloned ipaBΔ 3 into pUC18-oc 
by digesting pDR2 with SpeI and PstI and ligated into pIMC51 given rise to pIMC56. The SpeI-PstI digested frag-
ment was also cloned into pIMC43 generating the new plasmid pIMC47 containing ipaBxxx in cis with ipaBΔ 3.
# Primer name Sequencea
1 ipaBwt_no88a_RBSbad Fwd GCGAAGCTTCAGGAGGAATTAACCATGCATAATGTAAGCACCACAAC
2 ipaBΔ 2-20_no88a_RBSbad Fwd GCGAAGCTTCAGGAGGAATTAACCATGGAGCTTGGAGACAATACTATC
3 ipaB HindIII Fwd GGGGAAGCTTGATGCATAATGTAAGCACC
4 ipaB PstI Rev GGGGCTGCAGTCCTTATTTGTATCAAGCAG
5 ipaB SpeI Rev GCGCACTAGTTGAATAAAGGTTGCC
6 ipaB N85I-K93N Rev TTAATGCAGTTAAAGAGTTTTCACCGAGTATTTGAATAAGGATTCCAATTAAAAGC
7 ipaB N85I & K93N Fwd GCTTTTAATTGGAATCCTTATTCAAATACTCGGTGAAAACTCTTTAACTGCATTAAC
8 ipaBQ108L & N116I Fwd CTTGGAAGTCCCTGCAACAGGCAAGACAGCAAAAATACCTAGAATTCTC
9 ipaBQ108L & N116I Rev GAGAATTCTAGGTATTTTTGCTGTCTTGCCTGTTGCAGGGACTTCCAAG
10 ipaB K188E Fwd CTCACTATCGAAAAAGACGCAGCAGTTAAAGAC
11 ipaB K188E Rev GTCTTTAACTGCTGCGTCTTTTTCGATAGTGAG
12 ipaB_NdeI Fwd GCGCATATGCATAATGTAAGCACCACAACCACTG (pUC18-oc)
13 ipaB_BHI Rev CGCGGATCCTCAAGCAGTAGTTTGTTGC (pUC18-oc)
14 ipaD_EcoRV_Fwd GGAGATCAAATGATATCTCATAG (pUC18-oc)
15 ipaD_Δ 330-332-BHI_Rev CGCGGATCCTCAAAAAAGTTTATCTGTATCTGTAC (pUC18-oc)
16 ipaD_SacI_Fwd CGAAAAGAGCTCTAAGGAAATAACCATGAATATAACAACTCTGACTAATAG (pACT3)
17 ipaD_BHI_Rev CGCGGATCCTCAGAAATGGAGAAAAAG (pACT3)
18 ipaB_NcoI Fwd CGCGCCATGGATAATGTAAGCACCACAACCACTGG 
Table 3.  Primers used in this study. aRestriction sites are underlined.
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We also constructed a series of ipaD mutants in pUC18-oc12. We cloned the new ipaD constructs into 
pDR6-oc plasmid. We first reintroduced the native C322 into ipaD by digesting pipaD with EcoRV/PstI and ligat-
ing into pDR6-oc, creating pIMC61. We then constructed pIMC62 by ligating ipaDN186Y, K291I digested from 
pIMA237 with EcoRV and PstI into pDR6-oc. Then we made pIMC63 by deleting the last 3 aa of IpaD by PCR 
using pipaD as template and primers 14 and 15. PCR fragment was digested with EcoRV and BamHI and ligated 
into pDR6-oc. These primers were also used to obtained ipaDxxD3 by PCR, although in this case, pIMA237 was 
used as a template. The PCR fragment was digested and ligated into pDR6-oc given rise to pIMC64.
Combination of ipaB and ipaD mutants. To combine ipaB and ipaD in trans we constructed a series of 
ipaD mutants in pACT3. By PCR, using primers 16 and 17, we amplified ipaDx and ipaDxx from pIMA233 and 
pIMA237, respectively. PCR fragments were digested and ligated into pACT3 giving rise to pIMC58 and pIMC60. 
To amplify ipaDΔ 3 from pIMAC49, we used primers 15 and 16. After digestion with SacI/BamHI and ligation 
into pACT3, pIMC59 was obtained. ipaDwt was amplified from pipaD by PCR using primers 16 and 17. The PCR 
fragment was digested and cloned into pACT3 giving rise to pIMA246.
All plasmids created were verified by sequencing (Eurofins).
Expression of mxiQ51A in trans with ipaB and ipaD mutants. A series of ipaB and ipaD mutants 
cloned into pUC18-oc were co-expressed in trans with mxiHQ51A, expressed from pACT3.
Analysis of protein synthesis and secretion. Protein expression levels. Strains were grown at 37 °C 
until mid-exponential phase (OD600 = 1) was reached. Samples of the cultures were denatured in Laemmli sample 
buffer. Samples from equivalent cell numbers were separated by SDS-PAGE and Western blotted.
Exponential leakage. Strains were grown until OD600 = 1. Cultures were centrifuged at 15,000 g for 10 min at 4 °C 
and supernatants from equivalent cell numbers were subjected to SDS-PAGE and Silver-stained (Silver Xpress kit, 
Invitrogen) or Western blotted.
Congo red induction. Bacteria collected during mid-exponential growth were resuspended at OD600 = 5 
in phosphate-buffered saline (PBS). CR (Serva) was added at 100 μ g/ml. After incubation at 37 °C for 15 min, 
the samples were centrifuged at 15,000 g for 10 min at 4 °C and the supernatants separated by SDS-PAGE and 
Silver-stained or Western blotted.
Western blots. Proteins separated by SDS-PAGE were transferred onto PVDF membrane (Immobilon FL, 
Millipore) and hybridized with anti-IpaB, IpaC, IpaD, IpgD and IpaH43. Fluorescent secondary antibodies (goat 
anti-rabbit-Alexa680, Invitrogen; goat anti-rabbit-DyLight800 and goat anti-mouse-DyLight800, Pierce) were 
visualized and quantified using an Odyssey infrared imaging system (Li-Cor).
Characterization of the cellular interactions of ipaB mutants. Contact-mediated hemolysis. 
Contact hemolysis of sheep red blood cells (RBC) was performed as described previously23. PBS (Sigma) was used 
throughout.
Red blood cell membrane isolation. RBC membrane isolation was performed as described previously24.
Invasion assays. Gentamycin protection assays, were performed as previously described24 with small modifica-
tions. During the experiment HeLa cells were incubated in DMEM high glucose (Sigma) complemented with heat 
inactivated 10% fetal bovine serum (Sigma) to minimize cell stress caused by FBS depletion.
FACS analysis. FACS was used to assess the presence of IpaB, IpaD and MxiH on the Shigella surface as previ-
ously described12.
Confocal microscopy. HeLa cells were grown to 70% confluence on poly-lysine coverslips. Cells were infected 
with log phase Shigella at a MOI of 20. An Afa1-expressing bacteria strain was used to increase bacterial adhe-
sion61. The samples were centrifuged for 10 min at 900g at room temperature to synchronise adhesion, then incu-
bated for 6 min at 37 °C to initiate interaction with host cells. Cells were fixed with 2% PFA, blocked with 3% w/v 
BSA in PBS and then immunostained for 1 h at room temperature with anti-IpaD, anti-IpaH and anti-MxiH (see 
FACS section for santibody details). Host cell actin was stained with Alexa Fluor 488 Phalloidin (Life Technology) 
according to the manufacturer’s instructions. Samples were mounted with Mowiol. Images were taken using a 
Leica SP5-II confocal laser scanning microscope using a 63X oil objective.
Analysis of T3SS basal body abundance by electron microscopy. Bacterial cells were processed as described in 
Kenjale et al.17 to obtain cell ghosts. Electron micrographs were recorded on a FEI Tecnai T12 transmission 
electron microscope (TEM), operating at 100 kV. Images were acquired at a nominal magnification of 26,000X.
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